Thádia Evelyn de Araújo, Angelica Oliveira Gomes, Jordana Grazziela Coelho-Dos-Reis, Ana Carolina Aguiar Vasconcelos Carneiro, Anderson Silva Machado, Gláucia Manzan Queiroz Andrade, Daniel Vitor Vasconcelos-Santos, José Nélio Januário, Vanessa Peruhype-Magalhães, Andréa Teixeira-Carvalho, Ricardo Wagner Almeida Vitor, Lis Ribeiro do Valle Antonelli, Eloisa Amalia Vieira Ferro, Olindo Assis Martins-Filho
Journal: Clinical immunology (Orlando, Fla.) 2021;232():108859
PMID: 34563685
Changes in immune response of children with congenital toxoplasmosis (CT) regarding infection evolution and therapeutic intervention was addressed. Infants with CT presented increased counts of monocytes, CD3CD16CD56, CD3CD56 and CD4 T-cells 1-year after treatment onset (TOXO). Smaller numbers of CD3CD16CD56 and TCRγδ T-cells were specifically observed in infants with retinochoroidal lesions (L(+)). When infants were classified based on the baseline status, expansion of CD3CD16CD56 and CD4 T-cells were observed in L(+) who had active, active/cicatricial or cicatricial lesions. Infants who had active or active/cicatricial lesions display augmented numbers of monocytes, CD3CD16CD56, CD3CD56, CD8DR and TCRγδ T-cells and those with active/cicatricial or cicatricial at baseline displayed increase in CD14CD64 monocytes. Moreover, all L(+) had increased IFN-γ and IL-10 CD4 T-cells, while L(-) had increased ratios of TNF, IFN-γ and IL-4 NK-cells upon antigen-specific stimulation. Persistent alterations in leukocytes in TOXO suggest long-term sequels in the immune system of infants with CT.
Copyright © 2021 Elsevier Inc. All rights reserved.
Medical:
Research Materials:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.